Assessing efficacy and safety of rectally vs. intravenously administered Sibazon in treatment of generalized epileptic seizures in children

Objective: to prove the therapeutic equivalence and similar safety profile of “Sibazon, rectal solution” (international nonproprietary name: diazepam) and “Sibazon, solution for intravenous and intramuscular administration” in children with primary generalized and bilateral tonic, clonic and tonic-c...

Full description

Bibliographic Details
Main Authors: A. G. Prityko, K. V. Osipova, P. L. Sokolov, E. A. Ezhova, I. G. Kotel’nikova, E. G. Lukyanov, G. A. Osipova
Format: Article
Language:Russian
Published: IRBIS LLC 2021-10-01
Series:Эпилепсия и пароксизмальные состояния
Subjects:
Online Access:https://www.epilepsia.su/jour/article/view/723
_version_ 1797879398652706816
author A. G. Prityko
K. V. Osipova
P. L. Sokolov
E. A. Ezhova
I. G. Kotel’nikova
E. G. Lukyanov
G. A. Osipova
author_facet A. G. Prityko
K. V. Osipova
P. L. Sokolov
E. A. Ezhova
I. G. Kotel’nikova
E. G. Lukyanov
G. A. Osipova
author_sort A. G. Prityko
collection DOAJ
description Objective: to prove the therapeutic equivalence and similar safety profile of “Sibazon, rectal solution” (international nonproprietary name: diazepam) and “Sibazon, solution for intravenous and intramuscular administration” in children with primary generalized and bilateral tonic, clonic and tonic-clonic seizures.Material and methods. An open-label, randomized clinical trial on efficacy and safety was conducted in 20 patients suffering from epilepsy with generalized seizures aged 1 to 17 years. Clinical blood and urine tests, biochemical blood analysis were used for diagnostics (glucose, total protein, albumin, total bilirubin, cholesterol, aspartate aminotransferase, alanine aminotransferase, creatine phosphokinase, alkaline phosphatase, creatinine, urea, creatinine clearance), as well as data on electrocardiographic (ECG) and electroencephalographic (EEG) studies. The patients were divided into two groups: in Group 1 (n=8), a rectal solution was used, in Group 2 (n=12) – a solution for intravenous and intramuscular administration.Results. The number of cases in which seizures were completed within 10 minutes after using the drug without resuming within subsequent 60 minutes, in Group 1 was 7 (87.5%), and in Group 2 – 9 (75.0%) (Fisher exact test (FET): p=0.617). Repeated primary generalized or bilateral tonic/clonic/tonic-clonic seizures within 24 hours after drug administration, in Group 1 were absent in 5 (62.5%) patients, in Group 2 – in 6 (50%) (FET: p=0.670); within 48 hours after drug administration – in 5 (62.5%) and 7 (58.3%) children, respectively (FET: p=1.00). Physical examination revealed no pathology in all patients at the final visit. While comparing ECG and EEG data at the final visit, no inter-group differences were found by the number of children with deviations from the norm. The results of laboratory studies confirmed that using the studied drugs had no negative effect on the main indicators of clinical and biochemical blood tests as well as clinical urine analysis.Conclusion. The effectiveness of the rectal form of Sibazon in relieving pediatric generalized epileptic seizures is comparable to that of Sibazon for intramuscular administration. The drug rectal form, due to easy-to-use administration, is preferable for outpatient practice. “Sibazon, rectal solution” is safe and has good tolerability.
first_indexed 2024-04-10T02:46:59Z
format Article
id doaj.art-a8dde0c082b2440999bb7287cb5c8145
institution Directory Open Access Journal
issn 2077-8333
2311-4088
language Russian
last_indexed 2024-04-10T02:46:59Z
publishDate 2021-10-01
publisher IRBIS LLC
record_format Article
series Эпилепсия и пароксизмальные состояния
spelling doaj.art-a8dde0c082b2440999bb7287cb5c81452023-03-13T07:44:18ZrusIRBIS LLCЭпилепсия и пароксизмальные состояния2077-83332311-40882021-10-0113320021010.17749/2077-8333/epi.par.con.2021.096543Assessing efficacy and safety of rectally vs. intravenously administered Sibazon in treatment of generalized epileptic seizures in childrenA. G. Prityko0K. V. Osipova1P. L. Sokolov2E. A. Ezhova3I. G. Kotel’nikova4E. G. Lukyanov5G. A. Osipova6Voyno-Yasenetskiy Scientific and Practical Center for Specialized Medical Care to ChildrenVoyno-Yasenetskiy Scientific and Practical Center for Specialized Medical Care to ChildrenVoyno-Yasenetskiy Scientific and Practical Center for Specialized Medical Care to ChildrenMoscow Endocrine PlantMoscow Endocrine PlantVoyno-Yasenetskiy Scientific and Practical Center for Specialized Medical Care to ChildrenVoyno-Yasenetskiy Scientific and Practical Center for Specialized Medical Care to ChildrenObjective: to prove the therapeutic equivalence and similar safety profile of “Sibazon, rectal solution” (international nonproprietary name: diazepam) and “Sibazon, solution for intravenous and intramuscular administration” in children with primary generalized and bilateral tonic, clonic and tonic-clonic seizures.Material and methods. An open-label, randomized clinical trial on efficacy and safety was conducted in 20 patients suffering from epilepsy with generalized seizures aged 1 to 17 years. Clinical blood and urine tests, biochemical blood analysis were used for diagnostics (glucose, total protein, albumin, total bilirubin, cholesterol, aspartate aminotransferase, alanine aminotransferase, creatine phosphokinase, alkaline phosphatase, creatinine, urea, creatinine clearance), as well as data on electrocardiographic (ECG) and electroencephalographic (EEG) studies. The patients were divided into two groups: in Group 1 (n=8), a rectal solution was used, in Group 2 (n=12) – a solution for intravenous and intramuscular administration.Results. The number of cases in which seizures were completed within 10 minutes after using the drug without resuming within subsequent 60 minutes, in Group 1 was 7 (87.5%), and in Group 2 – 9 (75.0%) (Fisher exact test (FET): p=0.617). Repeated primary generalized or bilateral tonic/clonic/tonic-clonic seizures within 24 hours after drug administration, in Group 1 were absent in 5 (62.5%) patients, in Group 2 – in 6 (50%) (FET: p=0.670); within 48 hours after drug administration – in 5 (62.5%) and 7 (58.3%) children, respectively (FET: p=1.00). Physical examination revealed no pathology in all patients at the final visit. While comparing ECG and EEG data at the final visit, no inter-group differences were found by the number of children with deviations from the norm. The results of laboratory studies confirmed that using the studied drugs had no negative effect on the main indicators of clinical and biochemical blood tests as well as clinical urine analysis.Conclusion. The effectiveness of the rectal form of Sibazon in relieving pediatric generalized epileptic seizures is comparable to that of Sibazon for intramuscular administration. The drug rectal form, due to easy-to-use administration, is preferable for outpatient practice. “Sibazon, rectal solution” is safe and has good tolerability.https://www.epilepsia.su/jour/article/view/723epilepsychildrenstatus epilepticuscluster of seizuresanticonvulsantsdiazepamrectal form
spellingShingle A. G. Prityko
K. V. Osipova
P. L. Sokolov
E. A. Ezhova
I. G. Kotel’nikova
E. G. Lukyanov
G. A. Osipova
Assessing efficacy and safety of rectally vs. intravenously administered Sibazon in treatment of generalized epileptic seizures in children
Эпилепсия и пароксизмальные состояния
epilepsy
children
status epilepticus
cluster of seizures
anticonvulsants
diazepam
rectal form
title Assessing efficacy and safety of rectally vs. intravenously administered Sibazon in treatment of generalized epileptic seizures in children
title_full Assessing efficacy and safety of rectally vs. intravenously administered Sibazon in treatment of generalized epileptic seizures in children
title_fullStr Assessing efficacy and safety of rectally vs. intravenously administered Sibazon in treatment of generalized epileptic seizures in children
title_full_unstemmed Assessing efficacy and safety of rectally vs. intravenously administered Sibazon in treatment of generalized epileptic seizures in children
title_short Assessing efficacy and safety of rectally vs. intravenously administered Sibazon in treatment of generalized epileptic seizures in children
title_sort assessing efficacy and safety of rectally vs intravenously administered sibazon in treatment of generalized epileptic seizures in children
topic epilepsy
children
status epilepticus
cluster of seizures
anticonvulsants
diazepam
rectal form
url https://www.epilepsia.su/jour/article/view/723
work_keys_str_mv AT agprityko assessingefficacyandsafetyofrectallyvsintravenouslyadministeredsibazonintreatmentofgeneralizedepilepticseizuresinchildren
AT kvosipova assessingefficacyandsafetyofrectallyvsintravenouslyadministeredsibazonintreatmentofgeneralizedepilepticseizuresinchildren
AT plsokolov assessingefficacyandsafetyofrectallyvsintravenouslyadministeredsibazonintreatmentofgeneralizedepilepticseizuresinchildren
AT eaezhova assessingefficacyandsafetyofrectallyvsintravenouslyadministeredsibazonintreatmentofgeneralizedepilepticseizuresinchildren
AT igkotelnikova assessingefficacyandsafetyofrectallyvsintravenouslyadministeredsibazonintreatmentofgeneralizedepilepticseizuresinchildren
AT eglukyanov assessingefficacyandsafetyofrectallyvsintravenouslyadministeredsibazonintreatmentofgeneralizedepilepticseizuresinchildren
AT gaosipova assessingefficacyandsafetyofrectallyvsintravenouslyadministeredsibazonintreatmentofgeneralizedepilepticseizuresinchildren